[1] |
SHI Dandan, SUN Yiyao, CHEN Xiaoqi, YANG Fangming, ZHANG Chuanlei, WANG Xinting, YUAN Changwei, CHEN Xinju.
Curative effect of fuzheng xiaoliu granules in the treatment of primary liver cancer and analysis of serum metabolomics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1247-1262.
|
[2] |
DING Jiamin, WANG Youdi, ZHAO Xiali, JIANG Genfeng, CHEN Siwen, HONG Chengcheng, LI Shuqin, HU Weihua.
Study on the treatment of thin endometrium with growth hormone and vitamin E
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 857-862.
|
[3] |
LIU Yanzhi, WANG Yan, LIU Kaili, ZHOU Wenhua, ZHU Ping, WANG Yingli, DU Shouying.
Inhibition and mechanism of Xihuang pill on mice bearing hepatoma H22 tumor
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 754-761.
|
[4] |
WANG Xinli, XU Xiaqing, FANG Hanbing, GUO Yuzhong.
Study of TPA on enhancing the anti-tumor effects of cisplatin and reducing its renal toxicity
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 535-543.
|
[5] |
LI Yanyan, FANG Xiaojie, YIN Xin, SUN Xi, RAO Chunhui.
circZNF124 regulates the proliferation, migration and invasion of colorectal cancer SW620 cells by targeting miR-4262
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1231-1239.
|
[6] |
YE Kaili, ZHENG Wen, YE Qifa, YANG Lan .
Mechanism of CDK1 participates in the development of hepatocellular carcinoma and its inhibitor application value
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 1086-1094.
|
[7] |
LIU Zhuo, TAN Xiaoning, ZENG Puhua.
Research progress of glutamine metabolism in liver cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1159-1166.
|
[8] |
PENG Fusheng, HUANG Xiaohui, LI Peng, TANG Jian'er.
miR-34a inhibits proliferation of prostate cancer LNCaP cells by regulating androgen receptor gene
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(1): 10-17.
|
[9] |
HOU Bin, HUANG Weiping, YIN Zhongpu, HU Shousen.
lncRNA PCAT19 inhibits the proliferation and invasion of nasopharyngeal carcinoma cells by adsorbing miR-142-5p and regulating the expression of ING3 gene
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 721-727.
|
[10] |
WANG Gaoqing, JIANG Wei, HUA Yongfei.
Curative efficacy of retetrexel combined with laparoscopic hepatectomy in treatment of patients with primary liver cancer and its effects on liver function and CIART, AFP-L3 and GP73
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 752-756.
|
[11] |
TIAN Dahao, LU Linming, ZHI Hui, ZHOU Jue, WANG Xiaoqing, JIANG Yuhua.
AHVAC-I inhibits the proliferation in human primary gastric cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 505-511.
|
[12] |
ZHAO Miaohui, ZHOU Jiani, QI Yong.
Mulberry polysaccharides improves the chemotherapy of liver cancer ascites tumor-bearing mice by regulating the PI3K/AKT/mTOR pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 401-407.
|
[13] |
CHENG Jianping, LI Zhen, ZHAO Xiaolin, YANG Mengyuan, JI Xiwei, YU Jiufei.
Research on the expression of miR-186-5p in serum of patients with colon cancer#br#
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(10): 1097-1104.
|
[14] |
NIE Juan,CAO Yumei,YANG Dongmei,SUN Siyu,WANG Qiaoqiong, XIE Xuejiao, TUO Qinhui.
Roles of Prunella vulgaris L. in the proliferation and migration of vascular smooth muscle cells and its molecular mechanisms
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 977-982.
|
[15] |
GU Yanling, SHENG Yongjia, WANG Jin.
Polysaccharide inhibits tumor associated fibroblasts transformation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(3): 266-271.
|